[BIC-announce] Longitudinal studies that could be impacted by 3T MRI upgrade

[Rick Hoge]

Dear all,

As discussed in the BIC Meeting this afternoon, we are seeking to 
upgrade our 3T MRI to the Siemens Prisma platform within the next 12-18 
months.  Advantages include an improved channel count (up to 64 from 
32), improved gradient performance, and compatibility with future pulse 
sequence developments.

We are sensitive to the concern surrounding longitudinal studies, and 
will do our best to adapt the timing to accommodate these.

It would be helpful if any researchers could advise me of any studies 
where a change in scanner platform is of particular concern, for both 
the 1.5 and 3T platforms.  In particular it would be helpful to get the 
following info:

Name of PI
Name of study
When study started
When study would ideally end
How many subjects already scanned
How many remaining to scan
List of the scans you are doing (MPRAGE, EPI BOLD, diffusion, etc.)
Any non-product sequences (WiP or C2P) you use
What RF coil do you use?  (usually 12 or 32-channel)
Any specific concerns related to the upgrade

If could provide the above info, and cc Katerina at the bic-finance.mni 
email above, it would be a big help for planning.

Best regards,

Rick

---
Rick Hoge, Ph.D.
Director, MRI Unit
McConnell Brain Imaging Centre
Associate Professor of Neurology & Neurosurgery
Montreal Neurological Institute
McGill University
Tel.  514-398-1929
---